Posted on 05/25/2011 2:48:50 PM PDT by OL Hickory
Canadian researchers find a simple cure for cancer, but major pharmaceutical companies are not interested.
Researchers at the University of Alberta, in Edmonton, Canada have cured cancer last week, yet there is a little ripple in the news or in TV. It is a simple technique using very basic drug. The method employs dichloroacetate, which is currently used to treat metabolic disorders. So, there is no concern of side effects or about their long term effects.
(Excerpt) Read more at hubpages.com ...
Seems like Cancer has been “cured” more times than I can count, based on accounts heard in the media.
I get suspicious when I read this kind of article and the author appears to use it as a club to beat on pharmaceutical companies.
Idiotic drivel from the antitechnological mystics.
—yeah—use it with peach pits—(sarc)
Ditto. However, I had a science teacher back in high school who was a former cancer research professor at a major university. He became very jaded and left the industry to teach high school. He told us that he had worked on three major research projects where they came very close to developing treatments that would cure cancer. Just when they reached the next to the last major milestone/goal, their funding would get cut. He was convinced that cancer treatment is purely big business and those doing the treating don't want a cheap drug.
The referenced article is from 2007.
A small clinical trial was done at Univ Alberta - 50 patients - “inconclusive” results.
Don’t hold your breath on this one...
Makes sense. So which sort of entity will eventually come up with a “cure for cancer”? Certainly not by the government.
Insurance companies are the only group who would benefit financially from a cheap drug. Pharmaceutical companies and the NIH fund most private and university research programs. So I can’t even guess at an answer to your question.
Maybe an organization like Susan B. Komen can focus some attention on the issue if they really are interested in a “race for the cure.”
Susan G. Komen foundation is too busy funding Planned Parenthood (and their abortion induced breast cancer incidence) with our donations to worry about any cures.
But consider the impact a cheap cure for cancer will have on social security and other political & social structures.
There often seems to be more groups advocating a mass die off of the human race & population control than advocating practical life extension.
Who knows what forces are actually at work behind the scenes on cancer cures and other life-extension issues.
Why are Americans always the last to know these things.
apparently there are trials in many Countries.
“OUTRAGE IN BELGIUM! (25 Oct. 2008)
After the news story in the Belgium press of two terminally ill cancer patients who used DCA and are now on the road to recovery, the Belgium people are asking questions. “It has brought a lot commotion in Belgium. All the people are wondering why they haven’t heard from DCA any sooner! And they wonder why it isn’t recognized yet as an official medicine for cancer! They are shocked!” (additional Belgium link) (Google-translated English versions 1, 2) “
http://thedcasite.com/
If it really works, the health insurance companies will jump on it. Cancer is expensive.
DCA patent.
Viral Genetics (Symbol: VRAL) reports that a patent under which it is exclusively licensed, will be granted for using a compound known as DCA to treat cancer. DCA (dichloroacetic acid) has emerged as a compound that accelerates the destruction of tumors without the deleterious and debilitating side effects associated with chemotherapy or radiation. This is the first patent granted for the use of DCA to treat cancer, and represents a significant milestone in the company’s growth.
The United States Patent and Trade Office has announced that the patent calling for the use of Dichloroacetate (DCA) to treat Cancer will be issued to the University of Colorado (CU) - and licensed exclusively to Viral Genetics - as a result of the invention filed by Viral Genetics’ Lead Scientist, Dr. M. Karen Newell Rogers during her tenure at CU. Newell Rogers originally filed the patent application in 2003, based on research work she and colleagues had done relating to “systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors”. Her work has resulted in the granting of patent number 8,071,645, which will issue on December 6, 2011.
Full Release: http://markets.financialcontent.com/demo/?GUID=20016974&Page=MediaViewer&Ticker=VRAL
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.